Jacky Woo

Jacky Woo has extensive experience in the biopharmaceutical industry, with a focus on translational biology and biomarker sciences. Jacky most recently worked as a Senior Director of Translational Biology at Xencor. Prior to that, they held senior director positions at Schrödinger and Theravance Biopharma US, Inc., where they led clinical biomarker strategies for various clinical programs related to asthma, pulmonary fibrosis, COVID-19, and inflammatory bowel diseases. Before that, Jacky worked at Gilead Sciences, Apocell Bioscience, Facet Biotech, Protein Design Labs, and Sangstat, where they held various leadership roles in biomarker sciences and translational research. Throughout their career, Jacky has been involved in developing biomarker strategies, leading cross-departmental collaborations, and providing scientific expertise in oncology research and drug development.

Jacky Woo completed their PhD in Immunology from the University of Aberdeen between 1987 and 1990. Jacky later pursued a Master of Business Administration (MBA) in Business Administration and Management, General from San Jose State University from 1996 to 2000. There is no information available regarding Jacky Woo's education prior to their PhD or after their MBA. However, it is known that they attended La Salle College in Hong Kong at some point, though details such as the degree attained or field of study are not provided.